These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31092708)

  • 1. Insufficient Use of Corticosteroids without Immunosuppressants Results in Higher Relapse Rates in Takayasu Arteritis.
    Mutoh T; Shirai T; Fujii H; Ishii T; Harigae H
    J Rheumatol; 2020 Feb; 47(2):255-263. PubMed ID: 31092708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feasible maintenance dose of corticosteroid in Takayasu arteritis in the era of biologic therapy.
    Shirai T; Sato H; Fujii H; Ishii T; Harigae H
    Scand J Rheumatol; 2021 Nov; 50(6):462-468. PubMed ID: 33729078
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India.
    Goel R; Danda D; Joseph G; Ravindran R; Kumar S; Jayaseelan V; Jayaseelan L; Bacon P
    Semin Arthritis Rheum; 2018 Apr; 47(5):718-726. PubMed ID: 29096935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapy.
    Takai Y; Kuroda H; Misu T; Akaishi T; Nakashima I; Takahashi T; Nishiyama S; Fujihara K; Aoki M
    Mult Scler Relat Disord; 2021 Apr; 49():102750. PubMed ID: 33524925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of immunosuppressive and biological agents on refractory Takayasu arteritis patients unresponsive to glucocorticoid treatment.
    Ohigashi H; Tamura N; Ebana Y; Harigai M; Maejima Y; Ashikaga T; Isobe M
    J Cardiol; 2017 May; 69(5):774-778. PubMed ID: 27567177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid monotherapy for the management of Takayasu arteritis-a systematic review and meta-analysis.
    Misra DP; Rathore U; Patro P; Agarwal V; Sharma A
    Rheumatol Int; 2021 Oct; 41(10):1729-1742. PubMed ID: 34302232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
    Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
    Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of initial prednisolone dose with remission, relapse, and infectious complications in adult-onset minimal change disease.
    Tanabe K; Samejima KI; Fukata F; Kosugi T; Tsushima H; Morimoto K; Okamoto K; Matsui M; Eriguchi M; Maruyama N; Akai Y; Tsuruya K
    Clin Exp Nephrol; 2022 Jan; 26(1):29-35. PubMed ID: 34365595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined cyclosporine and prednisolone therapy using cyclosporine blood concentration monitoring for adult patients with new-onset minimal change nephrotic syndrome: a single-center pilot randomized trial.
    Shirai S; Imai N; Sueki S; Matsui K; Tominaga N; Sakurada T; Yasuda T; Kimura K; Shibagaki Y
    Clin Exp Nephrol; 2018 Apr; 22(2):283-290. PubMed ID: 28699032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.
    Schmidt J; Kermani TA; Bacani AK; Crowson CS; Matteson EL; Warrington KJ
    Arthritis Care Res (Hoboken); 2012 Jul; 64(7):1079-83. PubMed ID: 22328491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of combination tocilizumab and glucocorticoids as an induction therapy in patients with Takayasu arteritis: An observational study.
    Yoshida S; Suzuki E; Matsumoto H; Yokose K; Fujita Y; Temmoku J; Matsuoka N; Yashiro-Furuya M; Asano T; Sato S; Watanabe H; Migita K
    Mod Rheumatol; 2023 Mar; 33(2):360-366. PubMed ID: 35438750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Relapse Rate in Patients with Polymyalgia Rheumatica despite the Combination of Immunosuppressants and Prednisolone: A Single Center Experience of 89 patients.
    Okazaki S; Watanabe R; Kondo H; Kudo M; Harigae H; Fujii H
    Tohoku J Exp Med; 2020 Jun; 251(2):125-133. PubMed ID: 32581186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regressed coronary ostial stenosis in a young female with Takayasu arteritis: a case report.
    Yokokawa T; Kunii H; Kaneshiro T; Ichimura S; Yoshihisa A; Yashiro Furuya M; Asano T; Nakazato K; Ishida T; Migita K; Takeishi Y
    BMC Cardiovasc Disord; 2019 Apr; 19(1):79. PubMed ID: 30940076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leflunomide in Takayasu arteritis - A long term observational study.
    de Souza AW; de Almeida Agustinelli R; de Cinque Almeida H; Oliveira PB; Pinheiro FA; Oliveira AC; Sato EI
    Rev Bras Reumatol Engl Ed; 2016; 56(4):371-5. PubMed ID: 27476631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins reduce relapse rate in Takayasu arteritis.
    Kwon OC; Oh JS; Park MC; Hong S; Lee CK; Yoo B; Kim YG
    Int J Cardiol; 2019 Jul; 287():111-115. PubMed ID: 30824260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid control of disease activity by tocilizumab in 10 'difficult-to-treat' cases of Takayasu arteritis.
    Goel R; Danda D; Kumar S; Joseph G
    Int J Rheum Dis; 2013 Dec; 16(6):754-61. PubMed ID: 24382284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood-onset Takayasu arteritis -- experience from a tertiary care center in South India.
    Goel R; Kumar TS; Danda D; Joseph G; Jeyaseelan V; Surin AK; Bacon P
    J Rheumatol; 2014 Jun; 41(6):1183-9. PubMed ID: 24786922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of refractory Takayasu arteritis patients treated with biologics including ustekinumab.
    Gon Y; Yoshifuji H; Nakajima T; Murakami K; Nakashima R; Ohmura K; Mimori T; Terao C
    Mod Rheumatol; 2021 May; 31(3):678-683. PubMed ID: 32700985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features and Outcomes of Japanese Patients with Giant Cell Arteritis: A Comparison with Takayasu Arteritis.
    Yoshida S; Suzuki E; Sumichika Y; Saito K; Matsumoto H; Temmoku J; Fujita Y; Matsuoka N; Asano T; Sato S; Watanabe H; Migita K
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.